Durable Response to Osimertinib in a Chinese Patient with Metastatic Lung Adenocarcinoma Harboring a Rare EGFR L858R/D761Y Compound Mutation

Durable Response to Osimertinib in a Chinese Patient with Metastatic Lung Adenocarcinoma Harboring a Rare EGFR L858R/D761Y Compound Mutation

Yajie Zhu,1,* Jianning Tang,1,* Xin Li,1 Tian Qin,2 Yang Wei1 1Department of Medical Oncology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610041, People’s Republic of China; 2Burn...

Full description

Bibliographic Details
Main Authors: Zhu Y, Tang J, Li X, Qin T, Wei Y
Format: Article
Language:English
Published: Dove Medical Press 2020-10-01
Series:OncoTargets and Therapy
Subjects:
nsclc
egfr
compound mutation
icotinib
osimertinib
d761y
Online Access:https://www.dovepress.com/durable-response-to-osimertinib-in-a-chinese-patient-with-metastatic-l-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/durable-response-to-osimertinib-in-a-chinese-patient-with-metastatic-l-peer-reviewed-article-OTT

Similar Items